A Phase 1, Randomized, Open-Label Crossover Study to Evaluate the Safety and Pharmacokinetics of 400 Mg Albaconazole Administered to Healthy Participants as a Tablet Formulation Versus a Capsule Formulation
Clinical Pharmacology: Advances and Applications - New Zealand
doi 10.2147/cpaa.s39600
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2013
Authors
Publisher
Informa UK Limited